Transneural - Crunchbase Company Profile & Funding

Overview

Transneural

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Transneural

CB Rank

380786

Transneural is a biotechnology company that develops novel neuroplastogens to treat neuropsychiatric diseases.

Private

Issaquah, Washington, United States

transneural.com

Biotechnology

Neuroscience

Therapeutics

Key People

Charmaine Lykins: Chief Executive Officer
Past Role: Karuna Therapeutics, Chief Commercial Officer
Mark Demitrack: Chief Research and Development Officer
Past Role: Neuronetics, Vice President and Chief Medical Officer

Details

Legal Name

Transneural Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Phone Number

+1 619 780 7684

Contact Email

media@transneural.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

TN-001

A small molecule neuroplastogen designed to treat neuropsychiatric disorders without hallucinogenic effects.

Neuroplastogen Pipeline

A series of small molecule compounds aimed at treating various neuropsychiatric diseases by enhancing neuroplasticity without hallucinogenic effects.

Research & Development

Transneural is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...